Skip to main content

Table 1 Baseline characteristics of the participants

From: Prediction of cardiovascular events by central blood pressure using radial tonometry in type 2 diabetes mellitus patients

Baseline characteristics

Overall

(n = 515)

Primary endpoint (–)

(n = 423)

Primary endpoint ( +)

(n = 92)

P-value

Age (yr)

61.34 ± 12.1

60.48 ± 12.4

65.34 ± 9.5

 < 0.001

Male sex

283 (55.0)

231 (54.6)

52 (56.5)

0.827

Body mass index (kg/m2)

24.78 ± 3.4

24.72 ± 3.5

25.05 ± 3.2

0.395

Smoking

171 (33.6)

140 (33.4)

31 (34.4)

0.948

Diabetes complication

175 (34.0)

144 (34.0)

31 (33.7)

1.000

Diabetes duration (yr)

8.95 ± 8.7

8.56 ± 8.5

10.69 ± 9.6

0.044

HBP

334 (64.9)

271 (64.1)

63 (68.5)

0.495

CAD

209 (85.7)

149 (83.7)

60 (90.9)

0.222

Laboratory measurements

 Fasting blood glucose (mg/ dL)

159.38 ± 68.1

158.36 ± 67.1

164.00 ± 72.8

0.490

 HbA1c (%)

7.82 ± 1.9

7.84 ± 1.9

7.74 ± 1.5

0.682

 C-reactive protein (mg/dL)

0.82 ± 2.6

0.79 ± 2.6

0.97 ± 2.6

0.654

 eGFR (mL/min/1.73m2)

90.71 ± 29.8

92.38 ± 30.4

83.11 ± 25.8

0.008

 Total cholesterol (mg/dL)

173.68 ± 43.4

174.12 ± 42.6

171.67 ± 47.4

0.639

 Triglyceride (mg/dL)

150.93 ± 126.6

146.49 ± 113.0

171.04 ± 174.8

0.108

 LDL (mg/dL)

100.97 ± 34.8

101.58 ± 35.2

98.24 ± 32.9

0.427

 HDL (mg/dL)

40.83 ± 10.9

41.76 ± 11.0

36.62 ± 9.4

 < 0.001

Medication

 Oral hyperglycemic agent

446 (99.8)

370 (100.0)

76 (98.7)

0.385

 Insulin

110 (24.6)

93 (25.1)

17 (22.1)

0.674

 Lipid lowering agent

248 (48.2)

199 (47.0)

49 (53.3)

0.334

 Premedication

347 (67.4)

276 (65.2)

71 (77.2)

0.037

  ACEi, ARB

183 (39.4)

148 (38.8)

35 (41.7)

0.722

  Beta blocker

109 (23.4)

83 (21.8)

26 (31.0)

0.098

  Calcium channel blocker

129 (27.7)

103 (27.0)

26 (31.0)

0.554

  Diuretics

85 (18.3)

63 (16.5)

22 (26.2)

0.055

Baseline characteristics

Overall

Primary endpoint (–)

Primary endpoint ( +)

P-value

CBP (mmHg)

118.98 ± 20.7

117.98 ± 20.6

123.60 ± 20.6

0.018

SBP (mmHg)

131.05 ± 19.9

130.22 ± 19.7

134.86 ± 20.3

0.042

DBP (mmHg)

73.71 ± 12.2

73.75 ± 12.6

73.53 ± 9.9

0.874

Pulse pressure (mmHg)

57.34 ± 15.5

56.47 ± 15.1

61.33 ± 16.6

0.006

Augmentation index

79.75 ± 13.3

79.36 ± 13.2

81.50 ± 13.8

0.163

Heart rate

75.42 ± 13.3

75.50 ± 13.2

75.04 ± 13.9

0.775

  1. Data are presented as mean ± standard deviation or number (%)
  2. HBP High Blood Pressure, CAD Coronary Artery Disease, eGFR estimated Glomerular Filtration Rate, LDL Low-density Lipoprotein, HDL Highdensity Lipoprotein, ACEi Angiotensin Converting Enzyme inhibitor, ARB Angiotensin Receptor Blocker, CBP Central Blood Pressure, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure